These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Characteristics of 125I-iodocyanopindolol binding to beta-adrenergic and serotonin-1B receptors of rat brain: selectivity of beta-adrenergic agents.
    Author: Tsuchihashi H, Nakashima Y, Kinami J, Nagatomo T.
    Journal: Jpn J Pharmacol; 1990 Feb; 52(2):195-200. PubMed ID: 1968985.
    Abstract:
    The present study was designed to examine the specificity of beta-adrenergic antagonists for beta 1-, beta 2-adrenergic and 5HT1B-serotonergic receptors by the competitive interaction with 125I-iodocyanopindolol (125I-ICYP) as a radioligand. The beta 1-adrenoceptors were preferred by acebutolol, atenolol, betaxolol, practolol, and l-, dl- and d-metoprolol, while butoxamine and lCl-118,551 preferred beta 2-adrenoceptors. The selectivities of these beta 1- and beta 2-antagonists are well-known, but alprenolol which is known as a non-selective antagonist was 7.2-fold more selective for the beta 2-adrenoceptors in the present study. All beta-antagonists used were more selective towards beta-adrenoceptors as compared with 5HT1B-receptors. Good correlations were observed between the potencies of beta-adrenoceptor antagonists for inhibition of 125I-ICYP binding to beta 1- and beta 2-adrenoceptor sites and their potencies for inhibiting the binding of the same radioligand to 5HT1B-serotonergic receptor sites. These results suggest that beta-adrenoceptor antagonists can bind to beta-adrenoceptors and 5HT1B-receptors.
    [Abstract] [Full Text] [Related] [New Search]